Filing Details
- Accession Number:
- 0001209191-13-036533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-12 18:56:40
- Reporting Period:
- 2013-07-11
- Filing Date:
- 2013-07-12
- Accepted Time:
- 2013-07-12 18:56:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356857 | Trius Therapeutics Inc | TSRX | Pharmaceutical Preparations (2834) | 201320630 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1517780 | Michael Morneau | C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Dr, # 105 San Diego CA 92121 | Vp Finance & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-11 | 20,000 | $4.00 | 32,545 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-11 | 20,000 | $9.75 | 12,545 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-07-11 | 20,000 | $0.00 | 20,000 | $4.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,000 | 2020-08-31 | No | 4 | M | Direct |
Footnotes
- Includes 1,910 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
- 25% of the shares subject to the option vested on 1/1/11 with the remainder vesting monthly over 36 months until fully vested on 1/1/14.
Billionaire Hedge Funds
